The significance of Ras guanine nucleotide exchange factor, son of sevenless protein, in renal cell carcinoma cell lines

Journal of Urology

Volumn 158, Issue 3, 1997, Pages 908-911

  Shinohara, Nobuo ^a   Ogiso, Yoshifumi ^a   Tanaka, Motoyoshi ^a   Sazawa, Ataru ^a   Harabayashi, Tohru ^a   Koyanagi, Tomohiko ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Dominant negative H ras mutant; Guanine nucleotide exchange reaction; Renal cell carcinoma; Son of sevenless protein

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GUANOSINE TRIPHOSPHATE; RAS PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; ONCOGENE H RAS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030754123     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64362-3     Document Type: Article

References (20)

1. Kovacs, G. and Frisch, S.: Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res., 49: 651, 1989.
2. Shuin, T., Kondo, K., Torigoe, S., Kishida, T., Kubota, Y., Hosaka, M., Nagashima, Y., Kitamura, H., Latif, F., Zbar, B., Lerman, M. I. and Yao, M.: Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res., 54: 2852, 1994.
3. Fujita, J., Kraus, M., Onoue, H., Srivastava, S. K., Ebi, Y., Kitamura, Y. and Rhim, J. S.: Activated H-ras oncogenes in human kidney tumours. Cancer Res., 48: 5251, 1988.
4. Nanus, D. M., Mentle, I. R., Motzer, R. J., Bander, N. H. and Albino, A. P.: Infrequent ras oncogene point mutations in renal cell carcinoma. J. Urol., 143: 175, 1990.
5. Satoh, T., Nakafuku, M. and Kaziro, Y.: Function of Ras as a molecular switch in signal transduction. J. Biol. Chem., 267: 24149, 1992.
6. Boguski, M. S. and McCormick, F.: Proteins regulating Ras and its relatives. Nature, 366: 643, 1993.
7. Shou, C., Farnworth, C. L., Neel, B. G. and Feig, L. A.: Molecular cloning of cDNA encoding a guanine-nucleotide-releasing factor for Ras p21. Nature, 358: 351, 1992.
8. Chardin, P., Camonis, J. H., Gale, N. W., Van Aelst, L., Schlessinger, J., Wigler, M. H. and Bar-Sagi, D.: Human Sos 1: A guanine nucleotide exchange factor for ras that binds to Grb2. Science, 260: 1338, 1993.
9. ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell, 73: 611, 1993.
10. Yao, M., Shuin, T., Misaki, H. and Kubota, Y.: Enhanced expression of c-myc and epidermal growth factor receptor (c-erb B-1) genes in primary human renal cancer. Cancer Res., 48: 6753, 1988.
11. Oka, H., Chatani, Y., Hoshino, R., Ogawa, O., Kakehi, Y., Terachi, T., Okada, Y., Kawaichi, M., Kohno, M. and Yoshida, O.: Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res., 55: 4182, 1995.
12. Ogiso, Y., Yokoyama, T., Watari, H., Shih, T. Y. and Kuzumaki, N.: Resistance of NIH3T3 cells to v-fes transformation induced by a dominant negative H-ras mutant. Exp. Cell Res., 208: 415, 1993.
13. Yokoyama, T.: Inhibition of ras-dependent transformation by using dominant negative ras mutant N116Y. Hokkaido J. Med. Sci., 70: 459, 1995.
14. Hwang, Y.-W., Zhong, J.-M., Poullet, P. and Parmeggiani, A.: Inhibition of SDC25 C-domain-induced guanine-nucleotide exchange by guanine ring binding domain mutants of v-H-ras. J. Biol. Chem., 268: 24692, 1993.
15. Ogiso, Y., Sakai, N., Watari, H., Yokoyama ,T. and Kuzumaki, N.: Suppression of various human tumor cell lines by a dominant negative H-ras mutant. Gene Therapy, 1: 403, 1994.
16. Miyao, N., Tsukamoto, T. and Kumamoto, Y.: Establishment of three human renal cell carcinoma cell lines (SMKT-R-1, SMKT-R-2, SMKT-R-3) and their characters. Urol. Res., 17: 317, 1989.
17. Fujita, H., Suzuki, H., Kuzumaki, N., Mullauer, L., Ogiso, Y., Oda, A., Ebisawa, K., Sakurai, T., Nonomura, Y. and Kijimoto-Ochiai, S.: A specific protein, p92, detected in flat revertants derived from NIH/3T3 transformed by human activated c-H-ras oncogene. Exp. Cell Res., 186: 115, 1990.
18. Clanton, D. J., Hattori, S. and Shih, T. Y.: Mutations of the ras gene product p21 that abolish guanine nucleotide binding. Proc. Natl. Acad. Sci. USA, 83: 5076, 1986.
19. Daly, R. J., Binder, M. D. and Sutherland, R. L.: Overexpression of the Grb2 gene in human breast cancer cell lines. Oncogene, 9: 2723, 1994.
20. Stacey, D. W., DeGudicibus, S. R. and Smith, M. R.: Cellular ras activity and tumor cell proliferation. Exp. Cell Res., 171: 232, 1987.